Recent Articles from GlobeNewswire
Continuous workflow from first outreach through confirmatory due diligence helps teams move faster and make more confident decisions
By ToltIQ; Deal Engine · Via GlobeNewswire · February 12, 2026
Full Stock Availability Enabled Delivery in Under 48 Hours to Olympic Locations
By Lakeland Industries, Inc. · Via GlobeNewswire · February 12, 2026
With every dollar distributed throughout the Fiserv Deposit Network, INDX will bring additional deposits to Fiserv community bank and credit union clients
By Fiserv, Inc. · Via GlobeNewswire · February 12, 2026
PLANTATION, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Alliance Entertainment Holding Corporation (NASDAQ: AENT), a leading distributor and omnichannel fulfillment partner for entertainment and pop culture collectibles, announced today that it will exhibit at the New York Toy Fair (NYTF), taking place February 14–17, 2026 at the Jacob K. Javits Convention Center in New York City. The Company will showcase its expanding licensed collectibles portfolio, including a featured presentation of Handmade by Robots™, its distinctive vinyl figure brand known for its proprietary “knit-look” aesthetic.
By Alliance Entertainment · Via GlobeNewswire · February 12, 2026
WATERTOWN, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PsiThera, Inc. today announced that Chief Executive Officer Eric Shaff, Founder and Chief Innovation Officer Woody Sherman, Ph.D., and Chief Scientific Officer Camil Sayegh, Ph.D., will participate in a fireside chat at the Piper Sandler Virtual Novel Targets in Immunology Symposium being held on Friday, February 13, 2026, from 9:00 AM to 9:25 AM ET.
By PsiThera · Via GlobeNewswire · February 12, 2026
International Symposium on Endovascular Therapy (ISET) Convened Key Opinion Leaders to Discuss Advancements and Future Role of Endovascular Robotics
By Microbot Medical Inc. · Via GlobeNewswire · February 12, 2026
TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage innovator in interventional MRI (“iMRI”) procedures, is pleased to announce that it has received the 2025/2026 Mount Logan Award from INOVAIT, the Canadian national network for commercializing breakthroughs in image-guided therapy (IGT) and artificial intelligence (“AI”).
By Profound Medical Corp. · Via GlobeNewswire · February 12, 2026
Billings, Montana, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Bion Environmental Technologies, Inc. (OTC QB: BNET), a leader in advanced organic fertilizers produced from manure and other organic waste, issued the following statement regarding recent market activity.
By BION ENVIRONMENTAL TECHNOLOGIES INC · Via GlobeNewswire · February 12, 2026
By IDT Corporation · Via GlobeNewswire · February 12, 2026
CAMBRIDGE, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will report its fourth-quarter and full-year 2025 financial results on Thursday, February 26, 2026. Vericel’s management will host a conference call and webcast at 8:30 a.m. ET to discuss its financial results and business highlights.
By Vericel Corporation · Via GlobeNewswire · February 12, 2026
The latest GeneSiC™ 5th Generation Trench-Assisted Planar (TAP) SiC MOSFET technology delivers significant improvements in performance, reliability, and robustness for AI data centers, grid and energy infrastructure and, industrial electrification
By Navitas Semiconductor Corporation · Via GlobeNewswire · February 12, 2026
New patents granted in 2025 in Australia and Japan bolster global IP coverage for Aprea’s WEE1 and ATR programs. Core patent families are expected to provide exclusivity into 2045.
By Aprea Therapeutics · Via GlobeNewswire · February 12, 2026
EATONTOWN, N.J., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Climb Global Solutions, Inc. (NASDAQ:CLMB) (“Climb” or the “Company”), a value-added global IT channel company providing unique sales and distribution solutions for innovative technology vendors, will host a conference call on Thursday, February 26, 2026 at 8:30 a.m. Eastern time to discuss its financial results for the fourth quarter and full year ended December 31, 2025. The Company’s results will be reported in a press release prior to the call.
By Climb Global Solutions, Inc. · Via GlobeNewswire · February 12, 2026
LOS ANGELES, Feb. 12, 2026 (GLOBE NEWSWIRE) -- via IBN -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) and Sapu Bioscience today announced key advancements in its global intellectual property portfolio supporting OT-101, its proprietary TGF-β antisense therapeutic platform, strengthening protection across neurology, oncology, and central nervous system (CNS) drug delivery.
By Oncotelic Therapeutics, Inc. · Via GlobeNewswire · February 12, 2026
Successful inaugural engine restoration demonstrates strong EGT margin recovery and supports fleet transition strategy
By Willis Lease Finance Corp. · Via GlobeNewswire · February 12, 2026
Reborn Logistics Subsidiary Reports Preliminary Unaudited Q4 2025 Revenue of $2.5 Million and Operating Income of $0.6 Million
By Reborn Coffee, Inc. · Via GlobeNewswire · February 12, 2026
Kansas City, Mo., Feb. 12, 2026 (GLOBE NEWSWIRE) -- CRB announced today that John R. Lupa, Jr. has joined the firm as Vice President, National Construction. An engineering, construction and consulting partner to the life sciences and food and beverage industries, CRB brings Lupa’s more than 30 years of experience leading complex capital programs into its national construction leadership team. His appointment advances CRB’s ability to deliver construction‑led solutions that support clients developing large‑scale biopharma and F+B facilities.
By CRB Group, Inc. · Via GlobeNewswire · February 12, 2026
LOS ANGELES, Feb. 12, 2026 (GLOBE NEWSWIRE) -- PodcastOne (Nasdaq: PODC), a leading publisher and podcast sales network, today announced record financial results for the third quarter (“Q3 Fiscal 2026”) and first nine months (“YTD Fiscal 2026”) ended December 31, 2025 of its fiscal year ending March 31, 2026 ("Fiscal 2026"). PodcastOne will host a conference call and webcast today, February 12, 2026.
By PodcastOne · Via GlobeNewswire · February 12, 2026
New partnerships across North America, the U.K., and Australia reflect growing demand for self-optimizing stores that close gaps between merchandising intent and impact
By Optimum Retailing · Via GlobeNewswire · February 12, 2026
WEST CHESTER, Pa., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing and selling medications for skin diseases requiring medical interventions, today announced the appointment of Chris Chapman as its Chief Commercial Officer.
By Verrica Pharmaceuticals Inc. · Via GlobeNewswire · February 12, 2026
BEDFORD, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, February 26, 2026, to discuss its financial and operating results for the fourth quarter and full year of 2025.
By Lantheus Holdings, Inc. · Via GlobeNewswire · February 12, 2026
Wishlist now
By Outfit7 Limited · Via GlobeNewswire · February 12, 2026
Key Q4 and Full Year 2025 Highlights
By Conduent Business Services, LLC · Via GlobeNewswire · February 12, 2026
TEL AVIV, Israel, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Enlight Renewable Energy (TASE: ENLT; NASDAQ: ENLT), a leading global renewable energy developer and an independent power producer, today announced that it will host a virtual Investor Event on Monday, March 9, 2026, beginning at 10:00 a.m. ET.
By Enlight Renewable Energy Ltd. · Via GlobeNewswire · February 12, 2026
Thopaz+ becomes first system in newly created digital chest drainage category, available to over 1,400 hospitals within Vizient’s national network
By Medela · Via GlobeNewswire · February 12, 2026
SAN DIEGO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, today announced the appointment of Derrick C. Li as Chief Business Officer, as well as the expansion of Nelson Sun’s role to include Chief Operating Officer, in addition to his current role as Chief Financial Officer. The appointments are effective as of February 9, 2026.
By Aardvark Therapeutics, Inc. · Via GlobeNewswire · February 12, 2026
Power grid and other critical utilities to benefit from authID’s biometric platform
By authID Inc. · Via GlobeNewswire · February 12, 2026
LOS ANGELES, Feb. 12, 2026 (GLOBE NEWSWIRE) -- LiveOne (Nasdaq: LVO), an award-winning, creator-first music, entertainment, and technology platform, announced today its financial results for the third quarter (“Q3 Fiscal 2026”) and first nine months (“YTD Fiscal 2026”) ended December 31, 2025 of its fiscal year ending March 31, 2026 (“Fiscal 2026”). LiveOne will host a conference call and webcast today, February 12, 2026.
By LiveOne, Inc. · Via GlobeNewswire · February 12, 2026
MALVERN, Pa., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), today announced that an independent Data and Safety Monitoring Board (DSMB) has issued a positive recommendation regarding the safety of buntanetap at 6 months, supporting the continuation of the ongoing pivotal Phase 3 AD clinical trial without modification.
By Annovis Bio Inc. · Via GlobeNewswire · February 12, 2026
BOLTON, Ontario, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Husky Technologies™ (“Husky”), a GPGI company (NYSE: GPGI) and a global leader in sustainable injection molding solutions, today announced that Tracy Cordes has been appointed President, Service, replacing Tony Black, who will retire effective March 31, 2026, following more than five years of dedicated service.
By GPGI, Inc. · Via GlobeNewswire · February 12, 2026
IRVING, Texas, Feb. 12, 2026 (GLOBE NEWSWIRE) -- XBP Global Holdings, Inc. (“XBP Global” or “the Company”) (NASDAQ: XBP), a workflow automation leader that leverages decades of industry experience, a global footprint, and agentic AI to rethink business process automation and digital transformation, announced the launch of Enabling the Next Era of Hyper‑Automation, a company‑wide campaign that reflects its vision to redesign how work is executed by embedding intelligence, autonomy, and human judgment directly into enterprise workflows.
By XBP Global Holdings, Inc. · Via GlobeNewswire · February 12, 2026
STOUGHTON, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that it will report fourth quarter and full-year 2025 financial results before the market opens on Thursday, February 26, 2026. Following the release of the financials, the Company will host a live conference call and webcast at 8:00 a.m. ET.
By Collegium Pharmaceutical, Inc. · Via GlobeNewswire · February 12, 2026
BRISBANE, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies, today highlighted new survey findings released by the Voices for Non-Opioid Choices (Voices) coalition following the first year of the Non-Opioids Prevent Addiction (“NOPAIN”) Act.
By Pacira BioSciences · Via GlobeNewswire · February 12, 2026
SAN DIEGO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announced that it will present data on its novel approach to the use of BiTEs in solid tumors by utilizing its systemically delivered RedTail platform at the AACR Immuno-Oncology (AACR-IO) conference being held in Los Angeles, California, from February 18-21, 2026.
By Calidi Biotherapeutics, Inc · Via GlobeNewswire · February 12, 2026
First enterprise AI platform to support MCP Apps, enabling rich, interactive UIs directly within AI-powered conversations
By Airia · Via GlobeNewswire · February 12, 2026
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (Nasdaq: NHPAP / NHPBP) (“NHP”) announced today that it will release its financial results for the fourth quarter and full year ended December 31, 2025 before market open on Friday, February 20, 2026.
By National Healthcare Properties · Via GlobeNewswire · February 12, 2026
FORT COLLINS, Colo., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Woodward, Inc. (NASDAQ: WWD), a global leader in energy control solutions for the aerospace and industrial markets, has been recognized by Forbes as one of America’s Most Successful Mid‑Cap Companies for 2026. The annual ranking, developed using data from FactSet, evaluates companies on earnings growth, sales growth, return on equity, and total stock return over the past five years.
By Woodward, Inc. · Via GlobeNewswire · February 12, 2026
NBA legend Muggsy Bogues joins effort to detect and manage coronary artery disease in retired players using AI-powered Heartflow Analysis
By Heartflow, Inc. · Via GlobeNewswire · February 12, 2026
SAN DIEGO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, today announced that it has established Ardia Therapeutics, Inc. (Ardia), a new wholly-owned U.S. subsidiary. Ardia will support development of a new dermatology pipeline focused on lead asset, DIA-615, a potential topical treatment for a variety of inflammatory skin diseases, including psoriasis. Bryan Jones, Ph.D., has been named Chief Executive Officer of Ardia and has transitioned out of his current role at Aardvark as Chief Operating Officer to lead Ardia.
By Aardvark Therapeutics, Inc. · Via GlobeNewswire · February 12, 2026
A leading AI and humanoid robotics company has commercially available models designed, built and manufactured in the United States of America
By Onconetix, Inc. · Via GlobeNewswire · February 12, 2026
By Getty Images, Inc. · Via GlobeNewswire · February 12, 2026
Raja Patel named President among a set of leadership updates aligning AI across product, security, and go-to-market execution for measurable outcomes
By Sophos Inc. · Via GlobeNewswire · February 12, 2026
This recognition driven by client reviews reinforces BairesDev’s satisfaction scores, engineering excellence, and global delivery impact.
By BairesDev · Via GlobeNewswire · February 12, 2026
Conference Call to be held Wednesday, March 4, 2026, at 9:00 a.m. Central Time
By Orion Group Holdings, Inc. · Via GlobeNewswire · February 12, 2026
Salt Lake City, Utah, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on February 6, 2026, the Compensation Committee of Recursion's Board of Directors approved the grant of inducement restricted stock unit (RSU) awards covering 820,431 shares of its class A common stock in the aggregate to 17 new employees under Recursion's 2024 Inducement Equity Incentive Plan (the “2024 Plan”). Each award was granted as an inducement material to the employee's commencement of employment with Recursion, or a subsidiary of Recursion, pursuant to Nasdaq Listing Rule 5635(c)(4).
By Recursion Pharmaceuticals · Via GlobeNewswire · February 12, 2026
MACAU, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a world-class integrated resort located in Cotai, Macau, today reported its unaudited financial results for the fourth quarter and full year ended December 31, 2025.
By Studio City · Via GlobeNewswire · February 12, 2026
BIRMINGHAM, Ala., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Diversified Energy Company (NYSE: DEC, LSE: DEC) (“Diversified” or the "Company") is pleased to announce that the Company plans to publish its operational and financial results for the full-year ended December 31, 2025 (the “full-year results”) on Thursday, February 26th, 2026, after the U.S. market close. The Company will host a conference call at 8:30 AM EST (1:30:00 PM GMT) on Friday, February 27th to discuss the full-year results and make an audio replay of the event available shortly thereafter and until August 27th.
By Diversified Energy PLC · Via GlobeNewswire · February 12, 2026
MACAU, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Melco Resorts & Entertainment Limited (Nasdaq: MLCO) (“Melco Resorts” or the “Company”), a developer, owner, and operator of integrated resort facilities in Asia and Europe, today reported its unaudited financial results for the fourth quarter and full year ended December 31, 2025.
By Melco Resorts & Entertainment Limited · Via GlobeNewswire · February 12, 2026
DURHAM, N.C. , Feb. 12, 2026 (GLOBE NEWSWIRE) -- Velocity Clinical Research today announces the appointment of Dr. Ronnie Beboso as UK Medical Director, strengthening the organization’s medical leadership as it continues to scale its clinical operations across the UK and Europe.
By Velocity Clinical Research, Inc. · Via GlobeNewswire · February 12, 2026
The new partnership introduces smartphone-controlled multiplayer gaming to Škoda EVs, including Tetris® as a six-month Škoda-exclusive title, delivering a smarter, more social in-car gaming experience.
By AirConsole · Via GlobeNewswire · February 12, 2026
- PROPEL 3 successfully met the primary endpoint of change from baseline in AHV at Week 52 (p<0.0001)
By BridgeBio Pharma, Inc. · Via GlobeNewswire · February 12, 2026
By MicrobiotiX · Via GlobeNewswire · February 12, 2026
SOUTH SAN FRANCISCO, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies for patients with cancer, today announced that the first patient has been dosed in the PiNACLE – H2H Phase 3 trial evaluating rondecabtagene autoleucel (ronde-cel, also known as LYL314) compared to lisocabtagene maraleucel (liso-cel) or axicabtagene ciloleucel (axi-cel) for the treatment of patients with relapsed or refractory (R/R) large B-cell lymphoma (LBCL) receiving treatment in the second-line (2L) setting.
By Lyell Immunopharma, Inc · Via GlobeNewswire · February 12, 2026
By EDAP TMS S.A. · Via GlobeNewswire · February 12, 2026
By BitMEX · Via GlobeNewswire · February 12, 2026
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- AMC Networks Inc. (“AMC Networks” or the “Company”) (Nasdaq: AMCX) announced today that it will solicit consents (“Consents”) from the holders of its existing 10.50% Senior Secured Notes due 2032 (the “Notes”) to amend the indenture governing the Notes to (1) amend the covenant that limits restricted payments in order to permit buybacks, purchases, redemptions, retirements or other acquisitions of AMC Networks Inc.’s equity interests in an aggregate amount not to exceed $50,000,000; (2) revise the covenant that limits transfers or licenses of certain trademarks to unrestricted subsidiaries to only permit transfers of non-exclusive licenses; and (3) restrict investments in unrestricted subsidiaries made pursuant to the definition of “Permitted Investments” to certain specified clauses in such definition (the “Proposed Amendments”).
By AMC Networks Inc. · Via GlobeNewswire · February 12, 2026
TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 fourth quarter and full-year earnings conference call on Thursday, February 26, 2026 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks.
By Cronos Group Inc. · Via GlobeNewswire · February 12, 2026
The integration unlocks real-time, scalable stablecoin settlement for global payments and commerce
By Zero Hash · Via GlobeNewswire · February 12, 2026
$0.26 per share consideration represents a 36.8% premium to the 10-day VWAP of Fokus Mining shares on the TSXV as of February 11, 2026
By Gold Candle Ltd. · Via GlobeNewswire · February 12, 2026
CHANGCHUN, China, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Recently, a freshly restored theater in the heart of Changchun, capital of northeast China's Jilin Province, has ushered in the new year with a burst of orchestral sound - marking both a city history homecoming and an architectural revival.
By The Jilin Provincial Concert Hall · Via GlobeNewswire · February 12, 2026
VICTORIA, Seychelles, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Global crypto trading platform BYDFi participated as a sponsor of Solana Accelerate APAC at Consensus Hong Kong 2026, held alongside Consensus Hong Kong at the Hong Kong Convention and Exhibition Centre. The combined gathering brought founders, institutions, policymakers, and builders together, highlighting Hong Kong’s role as a leading regional hub and a key meeting point for Web3 and blockchain innovation.
By BYDFi Blockchain Limited · Via GlobeNewswire · February 12, 2026
This news release constitutes a "Designated News Release" incorporated by reference in the prospectus supplement dated December 9, 2024 to Fortis' short form base shelf prospectus dated December 9, 2024.
By Fortis Inc. · Via GlobeNewswire · February 12, 2026
VTAK has Agreed to Terminate its At-The-Market (“ATM”) Equity Offering Program
By Catheter Precision, Inc. · Via GlobeNewswire · February 12, 2026
PyroGenesis would build commercial fumed silica reactor for USD$20 million
By PyroGenesis Inc. · Via GlobeNewswire · February 12, 2026
METTAWA, Ill., Feb. 12, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Brunswick Corporation (NYSE: BC) today declared a quarterly dividend on its common stock of $0.44 per share.
By Brunswick Corporation · Via GlobeNewswire · February 12, 2026
European Fashion Retailer to Leverage AI-Native Tools
By Impact Analytics · Via GlobeNewswire · February 12, 2026
U.S.-based production strengthens supply chain resilience for key automotive manufacturer customer programs.
By Clarios · Via GlobeNewswire · February 12, 2026
By Gray Media · Via GlobeNewswire · February 12, 2026
TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- White Gold Corp. (TSX.V: WGO, OTCQX: WHGOF, FRA: 29W), is pleased to announce that David D’Onofrio, CEO, will present live at the Precious Metals & Critical Minerals Virtual Investor Conference hosted by VirtualInvestorConferences.com, on February 12th, 2026. The Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com.
By Virtual Investor Conferences · Via GlobeNewswire · February 12, 2026
SAN FRANCISCO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- LiveRamp® (NYSE: RAMP), the leading data collaboration platform, today announced that its Board of Directors increased the Company’s share repurchase authorization by $200 million to $1.5 billion and extended the expiration by one year to December 31, 2027.
By LiveRamp, Inc. · Via GlobeNewswire · February 12, 2026
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Marex Group plc (NASDAQ: MRX) today announced that it will release its fiscal 2025 fourth quarter and full year results before market open on Tuesday, March 3, 2026. The earnings release and supplementary materials will be available through the "Investors" section of the Marex website at https://ir.marex.com/.
By Marex Group plc · Via GlobeNewswire · February 12, 2026
Full-Year Total Revenue of $342.3 Million, an Increase of 3% Versus Prior Year. Total ARR of $359.1 Million, an Increase of 3% Versus Prior Year. Enterprise ARR of $287.2 Million, an Increase of 10% Versus Prior Year. Full-Year Operating Cash Flow of $27.4 Million
By Commerce.com, Inc. · Via GlobeNewswire · February 12, 2026
SINGAPORE, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer” or the “Company”), a world-leading technology company for Bitcoin mining and AI infrastructure, today released its unaudited financial results for the fourth quarter ended December 31, 2025.
By Bitdeer Technologies Group · Via GlobeNewswire · February 12, 2026
CC Pharma Agreement Bolsters Tilray’s UK Growth, Strengthening Distribution to Pharmacy and Hospital Channels
By Tilray Brands, Inc. · Via GlobeNewswire · February 12, 2026
– Appointment of an experienced Arvinas executive with a proven ability to drive strategy and innovation positions the company for continued momentum and long-term growth –
By Arvinas Inc. · Via GlobeNewswire · February 12, 2026
